






















































































































































dilute-lethal マウス２３）や pogo マウス２４）でも認められるた
め，特定のミュータント遺伝子とは関係がないと考えら
れる。
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エ細胞で TH発現異常が観察され（図４A），また，
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Cerebellar abnormalities in relation to the onset and/or development of ataxia in mice
with Ca2+ channelopathy
Kazuhiko Sawada, Hiromi Sakata-Haga, and Yoshihiro Fukui
Department of Anatomy, The University of Tokushima School of Medicine, Tokushima, Japan
SUMMARY
This review summarizes recent studies on the morphological abnormalities of cerebella
in four ataxic mutant mice, i.e., tottering mouse, leaner mouse, rolling mouse Nagoya (RMN)
and rockermouse. These mutants carry mutations in the Ca2+ channel α1A subunit gene, and
become useful models for human Ca2+ channelopathy such as episodic ataxia type-2 and famil-
ial hemiplegic migraine. Abnormal expression of tyrosine hydroxylase (TH) in some Purkinje
cells has been observed in tottering mice, leaner mice and RMN, but not in rocker mice.
However, Purkinje cells did not seem to synthesize catecholamines. Since the transcription
of the TH gene is facilitated by Ca2+, TH expression in the mutant Purkinje cells indicates fun-
ctional abnormality by alterations in intracellular Ca2+ concentrations. Corticotropin-releasing
factor (CRF) immunoreactivity in some climbing or mossy fibers was higher in RMN than in
controls. Double immunostaining for CRF and TH revealed a correspondence in the distri-
bution of TH-positive Purkinje cells to terminal fields of CRF-positive climbing fibers in
RMN. Therefore, CRF seems to alter granule and Purkinje cell functions, such as abnormal
TH expression, indicating the possible expression of ataxic symptoms.
Key words : mutant mouse, ataxia, Ca2+ channelopathy, tyrosine hydroxylase,
corticotropin-releasing factor
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